{"entity":{"type":"insider","cik":"0001299790","url":"/insider/0001299790","json_url":"/insider/0001299790.json","name":"Flagship Ventures Fund 2004 L P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2007-05-31","last":"2013-09-27","span_basis":"filed_date"},"name_variants":[{"name":"Flagship Ventures Fund 2004 L P","source":"filing","n_filings":5,"first_seen":"2007-05-31","last_seen":"2013-09-27"}],"transactions":[{"id":5452976,"accession":"0001209191-13-045956","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-045956","line_url":"/filing/0001209191-13-045956#line-2","is_derivative":false,"issuer_cik":"0001255927","issuer_name":"BIND Therapeutics, Inc","issuer_ticker":"BIND","issuer_name_source":null,"issuer_url":"/issuer/0001255927","owner_cik":null,"owner_name":"Flagship Ventures General Partner LLC; KANIA EDWIN M JR; Flagship Ventures Fund 2004 L P","owner_display_name":"Flagship Ventures General Partner LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":1562616.0,"shares_owned_after_display":"1,562,616","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-09-25","filed_date":"2013-09-27","scope":"insider"},{"id":5524883,"accession":"0001181431-13-019227","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-13-019227","line_url":"/filing/0001181431-13-019227#line-6","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund 2004 L P; KANIA EDWIN M JR; Flagship Ventures General Partner LLC; Flagship Ventures 2007 General Partner LLC; AFEYAN NOUBAR; Flagship Ventures Fund 2007, L.P.","owner_display_name":"Flagship Ventures Fund 2004 L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":491824.0,"shares_display":"491,824","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":3442768.0,"total_display":"3,442,768.00","total_whole":"3,442,768","shares_owned_after":1165786.0,"shares_owned_after_display":"1,165,786","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-25","filed_date":"2013-03-27","scope":"insider"},{"id":5649001,"accession":"0001179110-09-013533","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-09-013533","line_url":"/filing/0001179110-09-013533#line-1","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"ST NewcoGen LLC; NEWCOGEN EQUITY INVESTORS LLC; NEWCOGEN GROUP LLC; Flagship Ventures General Partner LLC; NewcoGen PE LLC; KANIA EDWIN M JR; NewcoGen Elan LLC; NewcoGen Group, Inc.; Flagship Ventures Fund 2004 L P; Flagship Ventures Management, Inc.","owner_display_name":"ST NewcoGen LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":242931.0,"shares_display":"242,931","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":12192640.0,"shares_owned_after_display":"12,192,640","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-18","filed_date":"2009-09-22","scope":"insider"},{"id":3955953,"accession":"0001179110-08-021551","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-08-021551","line_url":"/filing/0001179110-08-021551#line-1","is_derivative":false,"issuer_cik":"0001131095","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001131095","owner_cik":null,"owner_name":"AGTC ADVISORS FUND LP; AGTC Partners, L.P.; Flagship Ventures Fund 2004 L P; Flagship Ventures Management, Inc.; Flagship Ventures General Partner LLC; Applied Genomic Technology Capital Fund LP","owner_display_name":"AGTC ADVISORS FUND LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8620690.0,"shares_display":"8,620,690","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":11949709.0,"shares_owned_after_display":"11,949,709","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-23","filed_date":"2008-12-29","scope":"insider"},{"id":7128227,"accession":"0001179110-07-011728","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-07-011728","line_url":"/filing/0001179110-07-011728#line-2","is_derivative":false,"issuer_cik":"0001131095","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001131095","owner_cik":null,"owner_name":"Flagship Ventures Fund 2004 L P; Flagship Ventures Management, Inc.; Applied Genomic Technology Capital Fund LP; AGTC ADVISORS FUND LP","owner_display_name":"Flagship Ventures Fund 2004 L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":222222.0,"shares_display":"222,222","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":1999998.0,"total_display":"1,999,998.00","total_whole":"1,999,998","shares_owned_after":3329019.0,"shares_owned_after_display":"3,329,019","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-05-30","filed_date":"2007-05-31","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001385228","name":"BIND Therapeutics, Inc","url":"/issuer/0001385228","role":"Ten percent owner","n_filings":1,"first_seen":"2013-09-27","last_seen":"2013-09-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001373707","name":"TETRAPHASE PHARMACEUTICALS INC","url":"/issuer/0001373707","role":"Ten percent owner","n_filings":1,"first_seen":"2013-03-27","last_seen":"2013-03-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001274563","name":"HELICOS BIOSCIENCES CORP","url":"/issuer/0001274563","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2007-05-31","last_seen":"2009-09-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001299790","retrieved_at":"2026-08-22T11:29:48+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}